Get started
Award

2024NSFSC0742

Funded outputs count: 11
Funder award ID: 2024NSFSC0742
OpenAlex ID: G7993637718
Extended Lymphadenectomy is Associated with Better Survival Outcome in Resected T1b-T4 Gallbladder Cancer: A 505-Patient Cohort Study
2026 · Tianhao Chen, Yanwen Jin, et al. · Annals of Surgical Oncology
Construction and validation of a prediction model for textbook outcome in distal cholangiocarcinoma undergoing pancreaticoduodenectomy based on six machine learning algorithms
2026 · Si-qi Yang, Yu-long Cai, et al. · European Journal of Surgical Oncology
Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers
2026 · Muhammad Masroor Hussain, Sana Qammar, et al. · Journal of Gastroenterology and Hepatology · 2
PDF
Non-placement of nasogastric tube versus early removal of nasogastric tube in the enhanced recovery after surgery of hepatocellular carcinoma: a case control study
2026 · Zheng-Hua Li, Chen Yang, et al. · Perioperative Medicine
Identification of novel therapeutic targets and effective anticancer agents for gallbladder cancer by integrating bioinformatics analysis and experimental validation
2025 · Yanjie Zhong, Ruiqi Zou, et al. · Frontiers in Pharmacology · 1
PDF
Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma
2025 · Muhammad Masroor Hussain, Bi Feng, et al. · Cancer Medicine · 9
PDF
Analysis on clinicopathological characteristics and prognostic factors of adenoma-associated gallbladder carcinoma
2025 · Rui-Qi Zou, Fei Liu, et al. · Updates in Surgery
Identification of Core gene expression alterations regulated by gut microbiota in tumor progression and immunotherapy resistance through integrative pan-cancer analysis
2025 · Yanjie Zhong, Peiyan Sun, et al. · International Journal of Biological Macromolecules · 5
Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma
2025 · Yanjie Zhong, Antony Stalin, et al. · Scientific Reports · 3
PDF
Hepatobiliary organoid research: the progress and applications
2025 · Rui-Qi Zou, Yu-Shi Dai, et al. · Frontiers in Pharmacology · 7
PDF
Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post‐hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single‐center experience in China
2024 · Tian‐Run Lv, Wen‐Jie Ma, et al. · Cancer Medicine · 3
PDF
Year
Topic